A Study to Evaluate the Efficacy and Safety of Dapagliflozin in Patient With Type 2 Diabetes Mellitus and Hypertension
Clinical trial NCT05970237 · RECRUITING
Trial details
- NCT number
- NCT05970237
- Sponsor
- Boryung Pharmaceutical Co., Ltd
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-07-26
- Primary completion
- 2025-10-21
- Enrollment
- 9000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.